Optimal Planning of a Day 3 Cryopreserved(Frozen)-Thawed Embryo Transfer in a Natural Cycle With hCG Administration or After Spontaneous LH Peak?

• Status: Completed
• Trial end date: 2019-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of the study is to determine whether spontaneous LH peak is superior to human chorionic gonadotropin before a transfer of a day 3 frozen embryo.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universitair Ziekenhuis Brussel

Criteria

Inclusion Criteria:

• Natural cycles, in which a frozen-thawed day 3 embryo is replaced.

• Signed informed consent.

• Regular cycle (i.e. between 26 and 35 days)

• Normal transvaginal ultrasound at screening, without evidence of clinically significant abnormality consistent with finding adequate for ART with respect to uterus and adnexa.

• Embryos frozen by vitrification.

• Single or dual embryo transfer.

Exclusion Criteria:

• Known allergic reactions to progesterone products.

• Intake of experimental drug within 30 days prior to study start.

• Contraindication for pregnancy.

• Embryos of women above 39 years of age at the time of embryo freezing.

• Recipients of oocyte donation cycles